EA013167B1 - Стабильная твёрдая композиция сертиндола - Google Patents

Стабильная твёрдая композиция сертиндола Download PDF

Info

Publication number
EA013167B1
EA013167B1 EA200800774A EA200800774A EA013167B1 EA 013167 B1 EA013167 B1 EA 013167B1 EA 200800774 A EA200800774 A EA 200800774A EA 200800774 A EA200800774 A EA 200800774A EA 013167 B1 EA013167 B1 EA 013167B1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
wavelength
solid pharmaceutical
less
composition according
Prior art date
Application number
EA200800774A
Other languages
English (en)
Russian (ru)
Other versions
EA200800774A1 (ru
Inventor
Флемминг Энок Ольсен
Анна Равнхолт Кристенсен
Кен Лильегрен
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200800774A1 publication Critical patent/EA200800774A1/ru
Publication of EA013167B1 publication Critical patent/EA013167B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200800774A 2005-09-08 2006-09-06 Стабильная твёрдая композиция сертиндола EA013167B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200501255 2005-09-08
PCT/DK2006/050038 WO2007065448A1 (en) 2005-09-08 2006-09-06 Stable solid formulation of sertindole

Publications (2)

Publication Number Publication Date
EA200800774A1 EA200800774A1 (ru) 2008-06-30
EA013167B1 true EA013167B1 (ru) 2010-02-26

Family

ID=37697999

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800774A EA013167B1 (ru) 2005-09-08 2006-09-06 Стабильная твёрдая композиция сертиндола

Country Status (17)

Country Link
EP (1) EP1924261A1 (uk)
JP (1) JP2009507051A (uk)
KR (1) KR20080042102A (uk)
CN (1) CN101257906A (uk)
AR (1) AR056475A1 (uk)
AU (1) AU2006322460A1 (uk)
BR (1) BRPI0615630A2 (uk)
CA (1) CA2621866A1 (uk)
EA (1) EA013167B1 (uk)
IL (1) IL189541A0 (uk)
MX (1) MX2008002290A (uk)
NO (1) NO20081721L (uk)
NZ (1) NZ565330A (uk)
TW (1) TW200738239A (uk)
UA (1) UA97349C2 (uk)
WO (1) WO2007065448A1 (uk)
ZA (1) ZA200801169B (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
CN106344533A (zh) * 2009-01-29 2017-01-25 大日本住友制药株式会社 具有内核的口腔崩解片剂
FR2943061B1 (fr) * 2009-03-13 2011-02-25 Rhodia Operations Composes organophosphores, systemes catalytiques comprenant ces composes et procede d'hydrocyanation ou d'hydroformylation utilisant ces systemes catalytiques
CN107501177B (zh) 2012-07-16 2018-12-07 菲布罗根有限公司 脯氨酰羟化酶抑制剂的晶体形态
US8883823B2 (en) 2012-07-16 2014-11-11 Fibrogen, Inc. Crystalline forms of a prolyl hydroxylase inhibitor
KR102291860B1 (ko) * 2013-06-06 2021-08-20 피브로겐, 인크. Hif 하이드록실라제 억제자의 약학적 제형
US10406103B2 (en) 2013-11-19 2019-09-10 Siga Technologies Inc. Rehydration of micronized tecovirmimat monohydrate
JP2018172361A (ja) * 2016-10-14 2018-11-08 大原薬品工業株式会社 光安定性を改善した、デュロキセチンを含有する固形製剤

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
WO1997035584A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Method for treating pain
WO1997039752A1 (fr) * 1996-04-24 1997-10-30 Shionogi & Co., Ltd. Preparation et procede de production du sertindole
EP0830864A1 (en) * 1996-09-23 1998-03-25 Eli Lilly And Company Combination therapy for treatment of psychoses

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
WO1997035584A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Method for treating pain
WO1997039752A1 (fr) * 1996-04-24 1997-10-30 Shionogi & Co., Ltd. Preparation et procede de production du sertindole
EP0830864A1 (en) * 1996-09-23 1998-03-25 Eli Lilly And Company Combination therapy for treatment of psychoses

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ARTHUR H. KIBBE, PAUL J. WELLER: "Handbook of pharmaceutical Excipients - Coloring Agents, Third Edition" 2000, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, XP002420831 page 146, paragraph 7 *
DATABASE WPI Week 199303 Derwent Publications Ltd., London, GB; AN 1993-021397 XP002420935 & JP 04 346929 A (TAKADA SEIYAKU KK) 2 December 1992 (1992-12-02) abstract *
DATABASE WPI Week 199749 Derwent Publications Ltd., London, GB; AN 1997-535568 XP002420934 & WO 9739752 A1 (SHIONOGI & CO LTD.) 30 October 1997 (1997-10-30) abstract *

Also Published As

Publication number Publication date
IL189541A0 (en) 2008-08-07
AR056475A1 (es) 2007-10-10
NZ565330A (en) 2011-06-30
WO2007065448A1 (en) 2007-06-14
EP1924261A1 (en) 2008-05-28
UA97349C2 (uk) 2012-02-10
MX2008002290A (es) 2008-03-14
AU2006322460A1 (en) 2007-06-14
NO20081721L (no) 2008-04-08
CN101257906A (zh) 2008-09-03
EA200800774A1 (ru) 2008-06-30
BRPI0615630A2 (pt) 2016-11-16
ZA200801169B (en) 2010-07-28
KR20080042102A (ko) 2008-05-14
CA2621866A1 (en) 2007-06-14
JP2009507051A (ja) 2009-02-19
TW200738239A (en) 2007-10-16

Similar Documents

Publication Publication Date Title
EA013167B1 (ru) Стабильная твёрдая композиция сертиндола
JP2740993B2 (ja) 内服用新規医薬製剤
UA44766C2 (uk) Тверда пероральна лікарська форма, до складу якої входить оланзапін, та спосіб її виготовлення
JP4795955B2 (ja) 複数の被覆層を有するフィルムコーティング錠
RU2484829C2 (ru) Композиции стабильных тиакумицинов
US20140044784A1 (en) Combined formulation with improved stability
US11957791B2 (en) Methods
EP2645996A2 (de) Verfahren zur herstellung einer ppi-haltigen pharmazeutischen zubereitung
EP1720527A2 (en) A stable pharmaceutical composition comprising an acid labile drug
HRP20050544B1 (hr) Čvrsti oblik za oralnu upotrebu
JP2018177815A (ja) エスシタロプラム医薬組成物
EA001610B1 (ru) Препарат из покрытых частиц
EA007619B1 (ru) Пленочное покрытие для таблеток и каплет
CN104758265A (zh) 一种雷诺嗪缓释片药物组合物及其制备方法
AU2013365715A1 (en) A pharmaceutical composition containing candesartan cilexetil and amlodipine
JP4730985B2 (ja) 安定化された医薬製剤
CN109200032A (zh) 高载药量盐酸文拉法辛缓释微丸组合物和缓释胶囊及制法
WO2020111089A1 (ja) 医薬組成物
WO2023118082A1 (en) Multiparticulate albaconazole composition
MXPA03002013A (es) Comprimidos que contienen epinatina fabricados por compresion directa.
JP2020066634A (ja) 腸溶性高分子及び崩壊剤を含有する顆粒
US20070212412A1 (en) Stable solid formulation of sertindole
JP2020029447A (ja) 腸溶性高分子及び抗付着剤を含有する顆粒
WO2019134971A1 (en) Encapsulated particles comprising a pharmaceutically active ingredient
JP2020002129A (ja) 光変色性が改善された、デュロキセチン塩酸塩含有顆粒

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM